Eleven PhD positions are available in the Marie Sklodowska-Curie Doctoral Network “RBP- ReguNET – Deconstructing and Rewiring RNA-RBP regulatory networks”. RBP-ReguNet has been conceived to leverage new discoveries in RNA-binding protein (RBP) biology to identify druggable targets for a range of untreatable diseases, including cancer, neurological disorders, liver and infectious diseases. RBP-ReguNET is a consortium of high-profile universities, research institutions and companies located in Spain, France, Italy, Germany, UK, and the Netherlands.